ALLMedicine™ Retinal Vein Occlusion Center

Sep 22nd, 2021 - Branch retinal vein occlusion in a case of Best vitelliform maculopathy.|2021|Hasan N,Raj L,Sundar DM,Kumar P,|

Sep 22nd, 2021 - This study aimed to theoretically identify the vascular nature of the deep capillary plexus (DCP) by examining patients presenting with both paracentral acute middle maculopathy (PAMM) and prominent middle limiting membrane (p-MLM) sign and p-MLM ...

Sep 17th, 2021 - Bilateral Central Retinal Vein Occlusion: A Presenting Sign of an Ongoing Life-threatening Condition.|2021|Madeira C,Barbosa Breda J,Penas S,|

Sep 12th, 2021 - To evaluate macular microstructure alterations in the parafoveal nonperfusion areas of eyes with branch retinal vein occlusions (BRVO), and to investigate their impact on retinal sensitivity. This was a cross-sectional study including thirteen BRV...

Sep 11th, 2021 - To describe the presentation, management, and clinical outcomes of branch retinal vein occlusion (BRVO) in African American patients compared to patients of other racial or ethnic backgrounds. This retrospective cohort study included eyes diagnose...

Sep 3rd, 2019 - In August 2019, the European Society of Retina Specialists (EURETINA) published clinical practice guidelines on the management of retinal vein occlusion (RVO).[1] Patients with suspected retinal vein occlusion (RVO) should undergo a full ophthalmo...

May 14th, 2019 - The US Food and Drug Administration (FDA) has approved aflibercept (Eylea, Regeneron) injection solution to treat all stages of diabetic retinopathy, the manufacturer has announced. Aflibercept, a vascular endothelial growth factor (VEGF) inhibito...

May 14th, 2019 - The US Food and Drug Administration (FDA) has approved aflibercept (Eylea, Regeneron Pharmaceuticals) injection solution to treat all stages of diabetic retinopathy, the manufacturer has announced. Aflibercept, a vascular endothelial growth factor...

Aug 1st, 2017 - Peripheral Laser for Recalcitrant Macular Edema Owing to Retinal Vein Occlusion: The WAVE Trial Wykoff CC, Ou WC, Wang R, et al Ophthalmology. 2017;124:919-921 Study Summary The WAVE study was a 1-year, prospective, randomized, phase 4 trial that ...

Jul 24th, 2017 - Case Diagnosis Isolated chronic elevation of the optic disc with relatively preserved visual function raises suspicion for vitreopapillary traction (VPT). This diagnosis can be confirmed by OCT, as it was in this patient. Idiopathic intracranial h...